• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

    7/9/25 7:58:00 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care
    Get the next $OSRH alert in real time by email

    BELLEVUE, Wash. and ZUG, Switzerland, July 9, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the official roadmap for a targeted $50 million security token offering (STO) planned for launch in the second half of 2025 under Regulation D of the U.S. Securities Act. The token, with the working title OSRT, will be a securitized digital asset representing OSR Holdings' equity exposure and is designed to align with the company's blockchain-based capital strategy.

    OSR Holdings logo (PRNewsfoto/OSR Holdings)

    As part of this roadmap, Taekwondo Access Credit (TAC)—a utility token that rewards participation and has growing adoption in the global Taekwondo community —will be accepted alongside Bitcoin (BTC) and Tether (USDT) as eligible currencies for subscription to the OSRT offering. Taekwondo remains one of the world's most widely practiced martial arts, with an estimated 70 million practitioners of all ages across 190 countries. TAC has been selected as one of the subscription tokens for the upcoming STO, alongside BTC and USDT, for its possible real-world utility with blood glucose monitoring devices, details of which OSRH intends to announce in a forthcoming press release.

    BCM Europe intends to convert a substantial portion of its TAC holdings into BTC or USDT through market-based transactions prior to its anticipated participation. Due to the convertibility of TAC into OSRT and to ensure compliance and mitigate potential insider trading concerns, BCM Europe AG, the issuer of TAC and the largest shareholder of OSRH, will not be permitted to use TAC directly in subscribing to the OSRT offering. Other interested and eligible subscribers of OSRT will be able to use BTC, USDT, or TAC to acquire OSRT tokens.

    "Our upcoming STO is not just a tokenization of our equity – it's a foundational element of our long-term capital and treasury strategy," said Peter Hwang, CEO of OSRH. "We believe that our combined $50 million STO plan and $80 million equity line of credit (ELOC) from White Lion GBM Innovation Fund provides a credible and achievable path towards building a $100 million Bitcoin and USDT reserve on our balance sheet."

    Key Elements of the OSRT Security Token Roadmap:

    • Plan for up to $50 Million STO Under Reg D:

      OSR Holdings aims to raise up to $50 million in digital assets via the OSRT token in the second half of 2025, offered under Regulation D, targeting accredited investors.
    • Eligibility of BTC, USDT, and TAC:

      OSRT will be offered to accredited investors who may subscribe using BTC, USDT, or TAC, enabling diversified participation and aligning with OSRH's existing blockchain ecosystem partnerships.
    • Special Restrictions for BCM Europe AG:

      While TAC will be accepted from eligible investors in the STO, BCM Europe AG, as the issuer of TAC and a major shareholder of OSR Holdings, will not be permitted to subscribe using TAC directly. Instead, BCM Europe will convert its TAC holdings into BTC or USDT through market-based transactions, a process designed to avoid conflicts of interest and align with best practices on insider participation.
    • ELOC-Backed Liquidity Plan:

      In parallel to the STO, OSR Holdings continues to draw from its $80 million ELOC from White Lion GBM Innovation Fund, further reinforcing its capital base and enabling the company to scale its crypto holdings toward a realistic $100 million reserve.
    • Crypto-Healthcare Convergence Strategy:

      OSRH is integrating decentralized finance with healthcare innovation, supported by its unique ecosystem that includes TAC, which is already actively used within the global Taekwondo community. Additional announcements on TAC real-world integration with digital healthcare are planned for 3Q2025.

    "This roadmap represents a significant evolution in how public healthcare companies can engage with digital finance," said Chris Bang, Chief Financial Officer of OSRH. "By structuring this offering with both transparency and accessibility in mind, we aim to reach a new generation of investors while maintaining regulatory discipline and operational integrity."

    About OSR Holdings, Inc.

    OSR Holdings, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno-oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting-edge research and development. For more information, visit www.OSR-Holdings.com

    About BCM Europe AG

    BCM Europe AG is a healthcare and blockchain investment firm based in Zug, Switzerland. BCM Europe is the founding organization behind Taekwondo Access Credit (TAC), a utility token adopted globally in the martial arts community and traded on centralized exchanges.

    Forward-Looking Statements

    This press release includes forward-looking statements regarding the expected timeline and design of the OSRT security token offering and BCM Europe's participation strategy. These statements are subject to risks and uncertainties, including but not limited to regulatory approvals, market volatility, and technical readiness. The OSRT Token offering has not yet been approved by the Board of OSR Holdings and will proceed only upon satisfaction of applicable legal and regulatory requirements.

    Contact Information

    OSR Holdings, Inc.

    Investor Relations

    [email protected]

    +82-31-948-9419

    BCM Europe AG

    Media Relations

    [email protected]

    +41-41-725-0800

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/osr-holdings-announces-strategic-roadmap-for-tokenization-under-reg-d-framework-in-partnership-with-bcm-europe-ag-302501191.html

    SOURCE OSR Holdings Inc.

    Get the next $OSRH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OSRH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OSRH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fierz Reto Kaspar

    3 - OSR Holdings, Inc. (0001840425) (Issuer)

    10/24/25 12:58:23 PM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    $OSRH
    SEC Filings

    View All

    OSR Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - OSR Holdings, Inc. (0001840425) (Filer)

    10/16/25 11:10:18 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    SEC Form 8-K filed by OSR Holdings Inc.

    8-K - OSR Holdings, Inc. (0001840425) (Filer)

    9/23/25 8:40:55 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    OSR Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - OSR Holdings, Inc. (0001840425) (Filer)

    9/9/25 4:47:39 PM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    $OSRH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

    BELLEVUE, Wash., Oct. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH) today announced that it has executed a definitive agreement to acquire Woori IO Co., Ltd. ("WORIO"), a pioneer in noninvasive glucose monitoring (NIGM), via a comprehensive share exchange. The acquisition reinforces OSRH's dedication to advancing biomedical innovation by adding a potential breakthrough technology for diabetes care, bringing truly needle-free glucose monitoring closer to patients globally and promising a safer, more convenient and accurate alternative to currently available technologies.

    10/14/25 8:30:00 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

    BELLEVUE, Wash., Sept. 9, 2025 /PRNewswire/ -- OSR Holdings (NASDAQ:OSRH) today announced that on September 5, 2025, it received a written notification from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. The notice does not affect the listing of OSR Holdings' common stock, which will continue to trade on the Nasdaq Capital Market under the ticker symbol "OSRH." In accordance with Nasdaq rules, the Company has until Marc

    9/9/25 5:30:00 PM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

    BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a  global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH

    8/1/25 1:29:00 PM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    $OSRH
    Leadership Updates

    Live Leadership Updates

    View All

    OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

    BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Niethammer, M.D., Ph.D., as Chief Medical Officer of Vaximm AG, an OSR Company developing a platform of orally administered target-specific T-cell activators, including VXM01, a clinical stage anti-VEGFR-2. . Dr. Niethammer is an internationally recognized oncology expert with over two decades

    7/15/25 7:30:00 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care

    OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

    BASEL, Switzerland, March 25, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr. Constance Höfer as its new Chief Scientific Officer (CSO). Dr. Höfer, a seasoned leader in drug development with over 20 years of experience in oncology and immunology, will oversee OSR Holdings' scientific strategy and innovation pipeline. Dr. Höfer joins OSR Holdings from Merck Healthcare, where she led global programs spanning from preclinical to late-stage clinical development. Prior to Merck, she held senior leadership positions a

    3/25/25 7:00:00 AM ET
    $OSRH
    Medical/Dental Instruments
    Health Care